Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)

NCT04633226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL: V114

Sponsor

Merck Sharp & Dohme LLC